Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE i (Q38375032)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE i |
scientific article |
Statements
1 reference
Erectile dysfunction predicts cardiovascular events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial/Telmisartan Randomized AssessmeNt Study in ACE i (English)
1 reference
Salim Yusuf
1 reference
Jeffrey Probstfield
1 reference
Michael Böhm
1 reference
Magnus Baumhäkel
1 reference
Koon Teo
1 reference
Peter Sleight
1 reference
Peggy Gao
1 reference
Johannes F Mann
1 reference
Rafael Diaz
1 reference
Gilles R Dagenais
1 reference
Garry L R Jennings
1 reference
Lisheng Liu
1 reference
Petr Jansky
1 reference
ONTARGET/TRANSCEND Erectile Dysfunction Substudy Investigators
1 reference
15 March 2010
1 reference
1 reference
Identifiers
1 reference